Management of HIV-infected Patients: To what Extent are Guidelines Useful? -Results of a Nationwide Audit;Management HIV-infizierter Patienten: Anwendbarkeit von Richtlinien - Ergebnisse einer österreichweiten Umfrage

Acta Medica Austriaca

Volumn 25, Issue 1, 1998, Pages 21-26

  Armbruster, Christine ^a   Gmeinhart, B ^b  

^a Pulmologisches Zentrum   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

AIDS; Antiretroviral therapy; Guidelines; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; COTRIMOXAZOLE; GANCICLOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; ATTITUDE OF HEALTH PERSONNEL; AUSTRIA; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MEDICAL AUDIT; PRACTICE GUIDELINES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0031909067     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Armbruster Christine: Tagesstation - eine patienten-und personalorientierte sowie kosteneffektive Betreuungsform. Acta Med Austriaca 1995;22:12-16.
2. Armbruster C, Armbruster CH, Kriwanek S: Vollimplantierbare, permanente, zentralvenöse Kathetersysteme bei AIDS-Patienten - ein Weg zur Heimbetreuung oder ein nicht vertretbares Infektionsrisiko? Schweiz Med Wschr 1996;126:1597-1602.
3. Armbruster C, Vetter N: Heimbetreuung von AIDS-Patienten aus medizinischer und pflegerischer Sicht - ein Wiener Projekt. Acta Med Austriaca 1994; 21:14-16.
4. Centers for Disease Control: 1992 revised classification system for HIV-infection and expanded surveillance case definition for AIDS among adulescents and adults. MMWR 1992;41(RR-17):1-19.
5. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe VJ, Friedman HM, Merigan THC, Reichman RC, Hooper C, Corey L, for the AIDS Clinical Trials Group: Treatment of human immunodeficiency virus infection with Saquinavir, Zidovudine and Zalzitabine. N Engl J Med 1996;334:1011-1017.
6. Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, Gonzalez-Lahoz J, Stevens JW, Fiddian AP and the European-Australian Collaborative Group: Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. N Engl J Med 1993;329:297-303.
7. Danner SA, Carr A, Leonard JM, Lehman LM, Gudiol F, Gonzalez J, Raventos A, Rubio R, Bouza E, Pintado V, Aguado AG, DeLomas JG, Delgado R, Borleffs JCC, Hsu A, Valdes JM, Boucher CAB, Cooper DA, for the European-Australian Collaborative Ritonavir Study Group: A short-term study of the safety, pharmakokinetics and efficacy of Ritonavir, an inhibitor of HIV-1 protease. N Engl J Med 1995;333:1528-1533.
8. Fischl MA, Gordon M, Dickinson GM, La Voie L: Safety and efficacy of Sulfamethoxazole and Trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia. JAMA 1988;259:1185-1189.
9. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D, AZT Collaborative Working Group: The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind placebo-controlled trial. N Engl J Med 1987;317:185-191.
10. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker THJ, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PHD: Frequent detection and isolation of cytopathic retroviruses (HTLV III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-503.
11. Girard PM, Landman R, Gaudebout C, Lepretre A, Lottin PH, Michon C, DeTruchis P, Matheron S, Camus F, Farinotti R, Mache C, Coulaud J-P, Saimot AG: Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in Zidovudine-treated AIDS patients. Lancet 1989;I:1348-1353.
12. Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair JP, Niu M, Hirsch MS, Merigan THC, for the AIDS Clinical Trials Group Study 175 Study Team: A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-1090.
13. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
14. Ioannidis JPA, Cappelleri JC, Lau J, Skolnik PR, Melville B, Chalmers TC, Sacks HS: Early or deferred Zidovudine therapy in HIV-infected patients without an AIDS-defining illness. Ann Intern Med 1995;122:856-866.
15. Katzenstein DA, Hammer SM, Hughes MD, Gundacker H, Jackson JB, Fiscus S, Rasheed S, Elbeik T, Reichman R, Japour A, Merigan THC, Hirsch MS, for the AIDS Clinical Trials Group Study 175 Virology Study Team: The relation of virologic and immunologic markers to clinical outcomes after nueleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl Med 1996;335:1091-1098.
16. Kovacs JA, Masur H: Prophylaxis of Pneumocystis carinii pneumonia: An Update. J Infect Dis 1989;160:882-886.
17. Larder BA, Darby G, Richman DD: HIV with reduced sensitivity to Zidovudine (AZT) isolated during prolonged therapy. Science 1989;243:1731-1734.
18. Markowitz M, Saag M, Powderly WG, Hurley AM, Hsu A, Valdes JM, Henry D, Sattler F, La Marca A, Leonard JM, Ho DD: A preliminary study of Ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995;333:1534-1539.
19. Masur H, Michaelis MA, Greene JB, Onorate I, Van Stouw RA, Holzmann RS: An outbreak of community-acquired pneumocystis carinii pneumonia. N Engl J Med 1981;305:1431-1438.
20. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
21. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A, and The Multicenter AIDS Cohort Study Group: The rise of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. N Engl J Med 1990;322:161-165.
22. Ruskin J, Lu Riviere M: Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 1991;331:468-471.
23. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA: HIV viral load markers in clinical practice. Nature Medicine 1996;2:625-629.
24. Spector SA, Busch DF, Follansbec S, Squires K, Lalezari JP, Jacobson MA, Connor JD, Jung D, Shadman A, Mastre B, Buhles W, Drew WL, AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group: Pharmacokinetic, safety and antiviral profiles of oral Ganciclovir in persons infected with human immunodeficiency virus: A Phase I/II Study. J Infect Dis 1995;171: 1431-1437.
25. State-of-the-Art Conference on Azidothymidine therapy for early HIV-infection. Am J Med 1990;89:335-344.
26. Studies of the Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group: Mortality in patient with acquired immunodeficiency syndrome treated either with foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213-220.
27. Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS, Murphy RL, Hardy WD, Soeiro R, Fischl MA, Bartlett JG, Merigan THC, Hyslop NE, Richman DD, Valentine FT, Corey L, and the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases: Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322:941-949.